. Soluble Neurofascin Binds Schwann Cells but Not Neurons (A-D) Binding of NF186-Fc and NF155-Fc to DRG explants (in red). Cells were also labeled with antibodies to neurofilament to detect neurons ([A and C], in green) or S100 to detect Schwann cells ([B and D], in green) as indicated. Cell nuclei were labeled with DAPI ([A-H], in blue). (E) Binding of NF155-Fc to a Schwann cell that is aligned with a neurofilament-labeled axon. An enlarged image of the cell process spiraling around the axon is shown in the inset. (F-H) Binding of NF155-Fc (F), NF186-Fc (G), or L1-Fc (H) to isolated rat Schwann cells. Both neurofascin isoforms bound to most
for Neurofascin 1997). To test this possibility, we used the extracellular A rat Schwann cell cDNA library was constructed and domain of either the 186 kDa or 155 kDa isoforms of screened by expression cloning in order to isolate the neurofascin fused to human Fc (NF155-Fc, NF186-Fc) putative glial ligand for neurofascin. Plasmid pools made in binding experiments on mixed dorsal root ganglia from this cDNA library were transfected into COS7 (DRG) cultures. Both neurofascin isoforms bound excells, which were subsequently screened for their abilclusively to S100-positive Schwann cells and not to neurofilament-labeled axons (Figures 1A-1D ). Neuroity to bind NF-Fc, as previously described (Peles et al., 1995). One of six positive pools was further subdivided Fc was used in binding experiments on frozen sections of sciatic nerves, it specifically labeled the nodes of into smaller pools and rescreened until a single plasmid was isolated (Figure 2A ). Sequence analysis of this Ranvier, where both neurofascin and NrCAM are located ( Figure 2H ). Altogether, these experiments demcDNA clone revealed a single open reading frame of 1647 nucleotides, which encodes for a 549 amino acid onstrate that gliomedin binds specifically to the two IgCAMs that are found at the nodal axolemma. protein ( Figure 2B ). The predicted polypeptide has the hallmarks of a type II transmembrane protein, containing a short (15 aa) cytoplasmic tail at its amino terminus Gliomedin Is a Novel Component of PNS and a carboxy-terminal extracellular region, which inNodes of Ranvier cludes collagen triple helix repeats (COL) and a single
The localization of gliomedin in myelinated nerves was olfactomedin domain (OLF; Figures 2B and 2C ). This determined using polyclonal and monoclonal antibodprotein, which we termed "gliomedin," belongs to a ies to this protein in combination with antibodies to vargrowing family of olfactomedin-related molecules (Barious axonal or glial markers ( The interaction between gliomedin and the axonal IgCAMs may provide an inductive Schwann cell signal for suppression of gliomedin's expression by RNAi resulted in the abolishment of Na + channels and neurothe clustering of nodal components along the axolemma. To test this possibility, we examined whether fascin clustering at the axolemma. Importantly, Na + channel clusters were never detected in more than 350 the olfactomedin domain of gliomedin (OLF-Fc), which specifically binds neurofascin and NrCAM (Figure 2 ), MBP + GFP + internodes that lacked gliomedin, but were present at the edges of such internodes that still excould induce clustering of Na + channels in isolated DRG neurons. OLF-Fc was mixed with a Cy3-labeled pressed it. The inhibition of node formation was specific to gliomedin-RNAi, as clusters of Na + channels antibody to human Fc and was allowed to bind purified DRG neurons for 30 min at 23°C. Further aggregation and neurofascin were present adjacent to gliomedin at the edges of myelin internodes of noninfected cells (arof the bound OLF-Fc by incubating the cultures at 37°C for an additional 24 hr resulted in coclustering of neurorow in Figures 7A, 7B, 7D, and 7F ), or cells expressing MAG-RNAi (Figures 7C, 7E, and 7G) . Taken together fascin ( Figure 8A ), underscoring its role as the axonal receptor for gliomedin. Initial clustering of neurofascin with the inhibitory effect of NF-Fc described above, our 
Experimental Procedures Immunofluorescence and Immunoelectron Microscopy
Teased sciatic nerves and frozen sections were prepared and imTissue Culture Methods munolabeled as previously described (Poliak et al., 2002 (Poliak et al., , 2003 . A Dissociated rat DRG cultures were grown in Neurobasal medium detailed step-by-step protocol for tissue processing and immu-(Gibco) supplemented with B27 (Gibco) and 50 ng/ml NGF (Alonoelectron microscopy is available upon request. Briefly, fixed tismone labs) (NB medium) for 5 days before being used in binding sue was embedded in 7% agar noble, sectioned on a vibrotome, experiments. Purified DRG neurons were established by treating infiltrated in LR Gold, and embedded in gelatine capsules, followed dissociated mixed cultures with two cycles (2 days each) of NB by UV polymerization. Tissue sections on formvar-coated nickel medium containing 10 M uridine/10 M 5#-Fluoro 2#-deoxyuridine grids were blocked with 0.5 BSA, 0.5% gelatine from porcine skin, (Sigma) to eliminate fibroblasts and Schwann cells. Myelinating 0.1% Tween-20 in PBS, and incubated with affinity purified anti-DRG cultures were maintained for 2 days in NB medium and then gliomedin antibody in the same buffer for 2 hr in room temperature. switched to Basal Eagle's medium (BME; Gibco) containing ITS Grids were washed seven times in PBS and incubated for 1 hr with supplements (Sigma), 0.2% BSA, 4 g/l D-glucose, and 50 ng/ml goat anti-rabbit IgG conjugated to 10 nm gold (1:20; Aurion). Grids NGF (BN medium). Myelination was induced after an additional 10 were postfixed in 2% aqueous OsO 4 , stained with 2% uranyl acedays by the addition of 15% heat-inactivated FCS (Gibco) and 50 tate and Reynolds's lead citrate, and examined using a Philips CMg/ml L-ascorbic acid (Sigma) (BNC medium). Viral infection was 12 transmission electron microscope. carried out for 2 hr with 8 g/ml polybrene on the second, third, and fourth days after plating with undiluted viral stock; myelination was induced 6 days later and proceeded for an additional 12 days Fc-Fusion Binding, Clustering, and Perturbation Experiments before analysis.
Binding experiments were performed using various Fc-fusion proteins that were already incubated with Cy3-conjugated anti-human Expression Cloning Fc (Jackson Laboratories) as described previously (Gollan et al., Construction of the rat Schwann cell cDNA library and expression 2003). For clustering experiments, DRG neurons were grown for cloning was done essentially as described previously (Peles et al., 12-13 days on slides coated with 100 g/ml Poly-D-lysine (Sigma) 1995). One positive pool was subdivided and rescreened three adand 10 g/ml laminin (Sigma) before binding. The neurons were ditional times until a single clone (F10) was isolated. DNA sequencthen incubated with medium containing OLF-Fc, GLDN-Fc, or ing of the isolated clone was performed on both strands (GenBank IgSF4-Fc as described above, washed once with Neurobasal meaccession number AY266116). dium and grown for additional 48-72 hr in NB before fixing and staining. Quantification was done from two 72 hr and one 48 hr 
